Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1980 Feb;11(2):123–126. doi: 10.1128/jcm.11.2.123-126.1980

Inhibition of Pseudomonas aeruginosa slime production by staphylococcal extracellular product.

A M Shibl, I A Al-Sowaygh
PMCID: PMC273336  PMID: 6766950

Abstract

Staphylococcus aureus produced an inhibitory factor that suppressed slime formation by Psuudomonas aeruginosa but had little effect on the growth of the organism. The inhibitory factor was not found in broth cultures but could be extracted from cultures grown on solid agar. The inhibitory factor moderately inhibited gram-negative bacteria in addition to inhibiting a variety of gram-positive bacteria. The inhibitory factor was found to have a low molecular weight, as judged by its diffusibility, and it could be partially purified by gel filtration on Sephadex G-50. It was observed to be heat labile; however, its activity was stable within a wide pH range. The factor was resistant to deoxyribonuclease, ribonuclease, and lipase, but sensitive to trypsin. The role of the inhibition of slime production in pathogenicity is discussed.

Full text

PDF
123

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bottone E., Allerhand J., Pisano M. A. Characteristics of a bacteriocin derived from Streptococcus faecalis var. zymogenes antagonistic to Diplococcus peumoniae. Appl Microbiol. 1971 Aug;22(2):200–204. doi: 10.1128/am.22.2.200-204.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Doggett R. G., Harrison G. M., Carter R. E. Mucoid Pseudomonas aeruginosa in patients with chronic illnesses. Lancet. 1971 Jan 30;1(7692):236–237. doi: 10.1016/s0140-6736(71)90973-1. [DOI] [PubMed] [Google Scholar]
  3. Gagliano V. J., Hinsdill R. D. Characterization of a Staphylococcus aureus bacteriocin. J Bacteriol. 1970 Oct;104(1):117–125. doi: 10.1128/jb.104.1.117-125.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kilbourn J. P. Infection in cystic fibrosis. Lancet. 1970 Oct 24;2(7678):878–879. doi: 10.1016/s0140-6736(70)92050-7. [DOI] [PubMed] [Google Scholar]
  5. REEVES P. THE BACTERIOCINS. Bacteriol Rev. 1965 Mar;29:24–45. doi: 10.1128/br.29.1.24-45.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Smith H. Opportunistic infection. Br Med J. 1973 Apr 14;2(5858):107–110. doi: 10.1136/bmj.2.5858.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sutherland I. W. Bacterial exopolysaccharides. Adv Microb Physiol. 1972;8:143–213. doi: 10.1016/s0065-2911(08)60190-3. [DOI] [PubMed] [Google Scholar]
  8. Williams A. G., Wimpenny J. W. Exopolysaccharide production by Pseudomonas NCIB11264 grown in batch culture. J Gen Microbiol. 1977 Sep;102(1):13–21. doi: 10.1099/00221287-102-1-13. [DOI] [PubMed] [Google Scholar]
  9. deRepentigny J., Mathieu L. G., Coallier-Ascah J. Accroissement par Staphylococcus aureus de la résistance de la souris envers l'infection par Pseudomonas aeruginosa. Can J Microbiol. 1976 Jul;22(7):1024–1033. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES